Volume 35, Issue 4, Pages (October 2011)

Slides:



Advertisements
Similar presentations
FK506 Controls CD40L-Induced Systemic Autoimmunity in Mice
Advertisements

Volume 40, Issue 4, Pages (April 2014)
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Transforming Growth Factor-β Signaling Curbs Thymic Negative Selection Promoting Regulatory T Cell Development  Weiming Ouyang, Omar Beckett, Qian Ma,
Volume 43, Issue 4, Pages (October 2015)
Volume 41, Issue 1, Pages (July 2014)
Volume 26, Issue 3, Pages (March 2007)
Volume 34, Issue 3, Pages (March 2011)
Volume 30, Issue 4, Pages (April 2009)
Cheryl Y. Chan, Ashley L. St. John, Soman N. Abraham  Immunity 
Volume 40, Issue 2, Pages (February 2014)
Volume 32, Issue 3, Pages (March 2010)
Volume 33, Issue 3, Pages (September 2010)
Volume 34, Issue 2, Pages (February 2011)
Sarita Sehra, Ana P. M. Serezani, Jesus A. Ocaña, Jeffrey B
Volume 40, Issue 4, Pages (April 2014)
Volume 40, Issue 3, Pages (March 2014)
Functional Beta2-Integrins Restrict Skin Inflammation In Vivo
Beatrix Schäfer, PhD, Adrian M
Volume 43, Issue 2, Pages (August 2015)
Volume 43, Issue 1, Pages (July 2015)
Volume 17, Issue 12, Pages (December 2016)
Volume 23, Issue 6, Pages (December 2005)
Volume 42, Issue 5, Pages (May 2015)
Volume 138, Issue 2, Pages (February 2010)
Volume 37, Issue 1, Pages (July 2012)
B-1a and B-1b Cells Exhibit Distinct Developmental Requirements and Have Unique Functional Roles in Innate and Adaptive Immunity to S. pneumoniae  Karen.
Volume 41, Issue 1, Pages (July 2014)
Volume 29, Issue 6, Pages (December 2008)
Interleukin-1β But Not Tumor Necrosis Factor is Involved in West Nile Virus-Induced Langerhans Cell Migration from the Skin in C57BL/6 Mice  Scott N.
Volume 29, Issue 1, Pages (July 2008)
Mast Cells Play a Key Role in Host Defense against Herpes Simplex Virus Infection through TNF-α and IL-6 Production  Rui Aoki, Tatsuyoshi Kawamura, Fumi.
FK506 Controls CD40L-Induced Systemic Autoimmunity in Mice
Integrin αE(CD103) Is Involved in Regulatory T-Cell Function in Allergic Contact Hypersensitivity  Andrea Braun, Nadin Dewert, Fiona Brunnert, Viktor.
Superior Suppressive Capacity of Skin Tregs Compared with Lung Tregs in a Model of Epicutaneous Priming  Subhashree Mahapatra, Melanie Albrecht, Abdul.
Docosahexaenoic Acid Alleviates Atopic Dermatitis by Generating Tregs and IL-10/TGF- β-Modified Macrophages via a TGF-β-Dependent Mechanism  Sang-Chul.
Volume 42, Issue 2, Pages (February 2015)
Recipient B Cells Are Not Required for Graft-Versus-Host Disease Induction  Catherine Matte-Martone, Xiajian Wang, Britt Anderson, Dhanpat Jain, Anthony.
Invariant NKT Cells Suppress CD8+ T-Cell–Mediated Allergic Contact Dermatitis Independently of Regulatory CD4+ T Cells  Anne Goubier, Marc Vocanson, Claire.
A Mutation in the Nlrp3 Gene Causing Inflammasome Hyperactivation Potentiates Th17 Cell-Dominant Immune Responses  Guangxun Meng, Fuping Zhang, Ivan Fuss,
Volume 34, Issue 4, Pages (April 2011)
Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
Volume 48, Issue 4, Pages e4 (April 2018)
Volume 33, Issue 4, Pages (October 2010)
Natural IgE Production in the Absence of MHC Class II Cognate Help
Volume 41, Issue 4, Pages (October 2014)
Volume 37, Issue 5, Pages (November 2012)
Volume 32, Issue 5, Pages (May 2010)
Volume 38, Issue 3, Pages (March 2013)
Volume 34, Issue 3, Pages (March 2011)
Volume 22, Issue 5, Pages e5 (November 2017)
Volume 29, Issue 5, Pages (November 2008)
Volume 22, Issue 5, Pages e5 (November 2017)
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Volume 29, Issue 1, Pages (July 2008)
Volume 31, Issue 4, Pages (October 2009)
E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity  Jee H. Lee, Chris Elly,
Sarita Sehra, Ana P. M. Serezani, Jesus A. Ocaña, Jeffrey B
Volume 34, Issue 3, Pages (March 2011)
Volume 29, Issue 5, Pages (November 2008)
Volume 28, Issue 5, Pages (May 2008)
Volume 39, Issue 1, Pages (July 2013)
Volume 35, Issue 4, Pages (October 2011)
Volume 31, Issue 6, Pages (December 2009)
Volume 38, Issue 3, Pages (March 2013)
Volume 34, Issue 6, Pages (June 2011)
Volume 30, Issue 2, Pages (February 2009)
Volume 13, Issue 11, Pages (December 2015)
Volume 37, Issue 2, Pages (August 2012)
Volume 38, Issue 2, Pages (February 2013)
Presentation transcript:

Volume 35, Issue 4, Pages 562-571 (October 2011) Mast Cell Interleukin-2 Production Contributes to Suppression of Chronic Allergic Dermatitis  Alon Y. Hershko, Ryo Suzuki, Nicolas Charles, Damiana Alvarez-Errico, Jennifer L. Sargent, Arian Laurence, Juan Rivera  Immunity  Volume 35, Issue 4, Pages 562-571 (October 2011) DOI: 10.1016/j.immuni.2011.07.013 Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 IL-2 Is Important in Suppression of Oxazolone-Induced Chronic Dermatitis (A) Ear swelling during induction of disease in 8- to 10-week-old Il2−/− and Il2+/+ mice (n = 4 mice/group) (top). Total IgE levels (bottom left) and oxazolone-specific (Oxaz sp) IgE (bottom right) as measured in the serum by ELISA. (B) Disease course in WT C57BL/6 mice that were injected with anti-CD25 presensitization on day -1 (n = 5 mice/group) or postsensitization on day 7 (n = 4). Data are reported beginning at the day of challenge where detectable ear swelling might be expected. Each experiment was performed twice. (C) Sections of ear tissue (left) stained as indicated and quantitation of epidermal thickening (right). Abbreviations: epi, epidermis; col, collagen. Scale bars represent 50 μm. Statistical analysis was by two-way ANOVA (B) or by a two-tailed Student's t test (A and C [right]). Results are means ± SEM. ∗∗p < 0.01; ∗∗∗p < 0.001. See also Figure S1. Immunity 2011 35, 562-571DOI: (10.1016/j.immuni.2011.07.013) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 2 MCs Suppress Dermatitis and Expand in the Spleen (A) Comparison of ear swelling between KitW-sh/W-sh (n = 7 mice/group) and C57BL/6 (WT) mice (n = 6) (left) or KitW-sh/W-sh mice i.d. injected with C57BL/6-derived MCs (n = 5) (right). Graphs are from the same experiments but presented individually in comparison to WT for clarity. Two independent experiments were performed. Statistical analysis was by two-way ANOVA. (B) Toluidine blue staining for MC in the ear skin and draining cervical lymph node (LN). Tissues were harvested from WT and KitW-sh/W-sh mice i.d. injected with WT MCs after full treatment with oxazolone. Scale bars represent 200 μm. (C) Quantitation of MC numbers in tissues distal to the inflammatory site. All tissues were collected after completion of chronic dermatitis induction. HPF, high power field, ×200. Statistical significance was determined by a two-tailed Student's t test. Results (A and C) are means ± SEM. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. See also Figure S2. Immunity 2011 35, 562-571DOI: (10.1016/j.immuni.2011.07.013) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 3 The Spleen Exacerbates Dermatitis and Facilitates Anti-CD25 Enhancement or MC Suppression of Disease (A) Splenectomized (Spleen−) C57BL/6 (WT) mice (n = 5) were treated with either control IgG or anti-CD25 and with oxazolone to induce dermatitis. Ear swelling was compared to nonsplenectomized (Spleen+) littermates. (B) Draining cervical LNs were harvested for evaluation of total cell numbers. The LNs were extracted from normal and splenectomized mice shown in (A) after full treatment with acetone or oxazolone. (C) MCs were introduced through the tail vein prior to induction of oxazolone dermatitis, and tissues from the inflamed ear, draining lymph nodes (LN), and spleens (SPL) were stained with toluidine blue. Scale bars represent 100 μm. (D) Disease course in WT, KitW-sh/W-sh, or KitW-sh/W-sh mice after i.v. injection of MCs (n = 5). Two independent experiments were conducted. (E) Comparison of ear swelling between KitW-sh/W-sh mice and KitW-sh/W-sh mice after splenectomy or splenectomy and i.d. MC reconstitution (n = 5). Statistical analysis was done by a two-way ANOVA test (A, D, and E) or by a two-tailed Student's t test (B). Results are means ± SEM. ∗∗∗p < 0.001. See also Figure S3. Immunity 2011 35, 562-571DOI: (10.1016/j.immuni.2011.07.013) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 4 MC Recruitment and Disease Suppression Is IgE Dependent (A) Comparison between MC recruitment to the spleen (n = 6) and oxazolone-specific (Oxaz sp) IgE levels in the serum (n = 4) of C57BL/6 mice treated with oxazolone. Dermatitis was induced after presensitization treatment of mice with either control IgG or anti-CD25. (B) Kinetics of IgE and MC accumulation in the spleens of BALB/c mice, as measured on days 0, 17, and 27 of oxazolone dermatitis (n = 4). (C) MC numbers in the spleens of control (acetone) or oxazolone-challenged IgE-deficient (Igh-7−/−) in the absence (IgG only) or in the presence of anti-CD25 (n = 5). (D) Disease course in Igh-7−/− mice, as compared to C57BL/6 wild-type controls (Igh-7+/+) (n = 5). (E) Quantitation of MCs in the ears of the mice in (D). Three independent experiments were performed. Statistical analysis was by a two-tailed Student's t test (A, C, and E) or by two-way ANOVA (D). Results are means ± SEM. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. See also Figure S4. Immunity 2011 35, 562-571DOI: (10.1016/j.immuni.2011.07.013) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 5 MCs Cooperate with Treg Cells in Disease Suppression (A) Flow cytometric analysis of total cell populations extracted from tissues and stained for CD4 and Foxp3 (SPL, spleen; LN, cervical lymph node). Statistical analysis was by a two-tailed Student's t test. ns, not significant; nd, not detectable. (B) Ear swelling in C57BL/6 and KitW-sh/W-sh treated with oxazolone after presensitization injection with either control IgG or anti-CD25 (n = 5). Data are presented as mean ± SEM; statistical significance was determined by a two-way ANOVA, ∗∗∗p < 0.01. (C) Representative draining lymph nodes from mice with oxazolone dermatitis and corresponding H&E-stained sections. The circle indicates hemorrhage within the lymph node. Scale bars represent 50 μm. See also Figure S5. Immunity 2011 35, 562-571DOI: (10.1016/j.immuni.2011.07.013) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 6 Oxazolone Dermatitis Increases MC-IL-2 Production In Vivo (A) Quantitation of IL-2 production by in vitro stimulation of peritoneal- and bone-marrow-derived MC (PDMC and BMMC, respectively) after FcεRI or PMA + ionomycin stimulation. IL-2 was measured by ELISA. (B) Flow cytometric detection of IL-2+ MCs in the spleen of BALB/c mice with oxazolone dermatitis. This strain was preferred for cytometry over C57BL/6 because of the higher numbers of splenic MCs. (C) Immunofluorescent detection of IL-2 production in KitW-sh/W-sh mice reconstituted (i.v.) with BMMCs from Il2-/- and Il2+/+ mice. Double staining was done with anti-IL-2 (green) and anti-CD117 (Kit) (red), as indicated. Scale bars represent 30 μm. (D) Total numbers of IL-2+ MCs was determined in spleens harvested from BALB/c mice on days 0, 17, and 27 of oxazolone-induced dermatitis (n = 4). Data are means ± SEM and significance was determined by a two-tailed Student's t test (A) or by two-way ANOVA (D); ∗∗p < 0.01; ∗∗∗p < 0.001. See also Figure S6. Immunity 2011 35, 562-571DOI: (10.1016/j.immuni.2011.07.013) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 7 Splenic MC IL-2 Production Controls the Ratio of Activated T Cells:Treg Cells and Is Needed for Late-Stage Suppression of Dermatitis (A) Ear swelling in C57BL/6 mice or KitW-sh/W-sh mice reconstituted with Il2+/+ or Il2−/− MCs via an i.v. injection (n = 5). (B) FACS analysis of total cell populations from tissues of KitW-sh/W-sh mice after i.v. injection with either Il2+/+ or Il2−/− MCs and induction of oxazolone dermatitis (day 30). Activated T (Tact) cells are CD4+CD5+CD69+; regulatory T (Treg) cells are CD4+Foxp3+. Data are means ± SEM and significance was determined by two-way ANOVA (A) and a two-tailed Student's t test (B); ∗p < 0.05; ∗∗p < 0.01. See also Figure S7. Immunity 2011 35, 562-571DOI: (10.1016/j.immuni.2011.07.013) Copyright © 2011 Elsevier Inc. Terms and Conditions